DV
Dividend Vision

PRE — Prenetics Global Ltd

Prenetics Global Ltd (PRE)

Total return is -83.1% over the past 5.1 years, 175.7 points behind SPY at 92.6%. Its deepest 1-year drawdown was 34.4%.

Prenetics Global Limited is a consumer health sciences company operating in the United States and Hong Kong that focuses on advancing human health and longevity through science-backed products under the IM8 brand and a consumer genetic testing service through its CircleDNA brand, which uses sequencing technology to deliver personalized health reports. The company does not currently distribute dividends. This security appeals primarily to growth-oriented investors seeking exposure to personalized health and genetic testing markets rather than income-focused investors.

PRE key facts

Asset type
Stock
Asset class
Equity
Inception date
07/16/2021
Last close
$19.75
Market cap
$354,118,176
Average volume
96600.0
Beta
0.253
Payout ratio
0.0
Forward P/E
0.0
EPS
$-4.13